United States Over The Counter (OTC) Drugs Market Report by Product Type (Cough, Cold and Flu Products, Analgesics, Dermatology Products, Gastrointestinal Products, Vitamins, Minerals and Supplements (VMS), Weight-loss/Dietary Products, Ophthalmic Products, Sleeping Aids, and Others), Route of Administration (Oral, Parenteral, Topical, and Others), Dosage Form (Tablets and Capsules, Liquids, Ointments, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others), and Region 2024-2032

United States Over The Counter (OTC) Drugs Market Report by Product Type (Cough, Cold and Flu Products, Analgesics, Dermatology Products, Gastrointestinal Products, Vitamins, Minerals and Supplements (VMS), Weight-loss/Dietary Products, Ophthalmic Products, Sleeping Aids, and Others), Route of Administration (Oral, Parenteral, Topical, and Others), Dosage Form (Tablets and Capsules, Liquids, Ointments, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others), and Region 2024-2032

Report Format: PDF+Excel | Report ID: SR112024A5857
Buy Now

United States Over the Counter (OTC) Drugs Market Size:

The United States over the counter (OTC) drugs market size reached US$ 25.4 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 37.6 Billion by 2032, exhibiting a growth rate (CAGR) of 4.45% during 2024-2032. The increasing consumer health awareness, cost-effectiveness of OTC drugs, regulatory support for prescription to OTC switches, rising aging population, and technological advancements in drug development and e-commerce are some of the factors propelling the market growth.

Report Attribute
Key Statistics
Base Year
2023
Forecast Years
2024-2032
Historical Years
2018-2023
Market Size in 2023 US$ 25.4 Billion
Market Forecast in 2032 US$ 37.6 Billion
Market Growth Rate 2024-2032 4.45%


United States Over the Counter (OTC) Drugs Market Analysis:

  • Major Market Drivers: The rising health awareness among consumers, the increasing preference for self-medication, and the cost-effectiveness of OTC drugs compared to prescription medications are the major drivers of the market in the United States. Regulatory initiatives promoting the switch from prescription to OTC status to enhance accessibility further stimulate the market.
  • Key Market Trends: The rising digitalization of pharmacies along with the increasing shift toward online sales and e-commerce platforms enhancing accessibility are the key trends of the market in the United States. There is also a growing focus on natural and organic OTC products driven by consumer demands for healthier alternatives which is influencing the market across the US.
  • Competitive Landscape: The competitive landscape of the market is highly dynamic and is dominated by several major pharmaceutical giants. Various companies compete through extensive product portfolios from last strong brand loyalty, and aggressive marketing strategies. The market also experiences competition from generic manufacturers and new entrants introducing innovative products.
  • Challenges and Opportunities: The United States over the counter (OTC) drugs market growth faces various challenges such as strict regulatory requirements which can delay product launches and increase costs. However, the market also witnesses several opportunities such as ongoing shift from prescription to OTC medications which can expand market potential and consumer base.


United States Over the Counter (OTC) Drugs Market Trends:

Rising Trend of Self-Care and Self-Medication

The increasing trend among people in the United States to self-medicate for minor health issues rather than seek professional medical advice is driving the demand for OTC drugs in the United States. This is primarily attributed to the growing convenience, affordability, and accessibility of OTC drugs, which allow consumers to take an active role in managing their healthcare. According to the National Centre of Biotechnology Information, common ailments for which self-medication was used frequently were fever, body aches, common cold, and cough. According to an article by Frontier, the prevalence of self-medication in America (47.8%, 95% Cl: 33.6-62) was higher than in Africa (41.5%, 95% Cl: 29.5-53.5). The major self-medication agents were paracetamol, vitamin C, zinc, multivitamins common vitamin D, azithromycin, cough syrup, and ibuprofen. This is further influencing the United States over the counter (OTC) drugs market statistics.

Growing Shift Towards OTC Drugs

The market is benefiting from the conversion of certain prescription drugs to OTC status. This switch trend enables consumers to access effective treatments for various conditions without a prescription which is further driving the growth of the market across the United States. According to the Consumer Healthcare Products Association, OTC medicines provide additional value through expanded access to over 27 million consumers (and $5 billion in potential savings) and productivity savings ($34 billion). On average US households spend about $442 annually on OTC products. As such, consumers have benefited from self-treating conditions like the common cold, allergies, body pain, upper on lower gastrointestinal tract issues, fungal infections, skin inflammations, smoking cessations, and difficulty falling asleep. This is further expected to fuel the United States over the counter (OTC) drugs market forecast over the coming years.

Increasing Healthcare Savings from OTC Drugs

OTC drugs provide significant cost savings to the healthcare system by reducing the need for doctor visits and prescription medications which is acting as a major growth-inducing factor in the market across the United States. This is a significant factor driving the adoption of OTC drugs as consumers and the healthcare system alike seek to manage costs. According to the Consumer Healthcare Products Association, the availability of OTC medicines provides $146 billion in value to the US healthcare system annually. Each dollar spent on OTC medicine saves more than $7 for the US healthcare system. Odyssey medical devices for treatment and testing generate an additional value of $8 billion for the U.S. healthcare system.

United States Over The Counter (OTC) Drugs Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the country and regional levels for 2024-2032. Our report has categorized the market based on product type, route of administration, dosage form, and distribution channel.

Breakup by Product Type:

  • Cough, Cold and Flu Products
  • Analgesics
  • Dermatology Products
  • Gastrointestinal Products
  • Vitamins, Minerals and Supplements (VMS)
  • Weight-loss/Dietary Products
  • Ophthalmic Products
  • Sleeping Aids
  • Others
     

Vitamins, Minerals and Supplements (VMS) accounts for the majority of the market share

The report has provided a detailed breakup and analysis of the market based on the product type. This includes cough, cold and flu products, analgesics, dermatology products gastrointestinal products, vitamins, minerals and supplements (VMS), weight loss/dietary products, ophthalmic products, sleeping aids, and others. According to the report, vitamins, minerals and supplements (VMS)represented the largest segment.

The evolving consumer health consciousness and lifestyle trends, coupled with the increasing emphasis on preventive health care and holistic Wellness are prompting individuals to proactively seek dietary additives to fill potential nutrient caps and support overall health, fueling the demand for OTC vitamins, minerals, and supplements. The modern diet, often lacking in essential nutrients is contributing to the interest in VMS products, strengthening the market growth. The convenience of OTC availability aligns with the preference for self-care, encouraging consumers to integrate supplements into their daily routines without the need for medical prescription, thereby bolstering the United States over the counter (OTC) drugs market demand.

Breakup by Route of Administration:

  • Oral
  • Parenteral
  • Topical
  • Others
     

Oral holds the largest share of the industry

A detailed breakup and analysis of the market based on the route of administration have also been provided in the report. This includes oral, parenteral, topical, and others. According to the report, oral accounted for the largest United States over the counter (OTC) drugs market share.

The ease of administration through oral consumption makes these drugs a convenient choice for individuals seeking quick relief from common ailments like pain, fever, allergies, and digestive discomfort, impelling the demand for oral OTC drugs. Oral OTC drugs often offer a faster onset of action compared to topical alternatives, making them an appealing option for rapid symptom relief, and aiding in market expansion. The familiarity with the oral drug format and its long-standing presence in the market also contributes to consumer trust and preference.

Breakup By Dosage Form:

  • Tablets and Capsules
  • Liquids
  • Ointments
  • Others
     

Tablets and capsules represents the leading market segment

The report has provided a detailed breakup and analysis of the market based on the dosage form. This includes tablets and capsules, liquids, ointments, and others. According to the report, tablets and capsules represented the largest segment.

The increasing demand for OTC tablets and capsules is propelling the market growth as they are the convenient and standardized method of medication delivery, ensuring accurate dosing and ease of consumption. Concurrent with this, tablets and capsules are often chosen for their portability, allowing individuals to carry and take their medications on the go, fitting seamlessly into busy lifestyles. Their solid forms also contribute to longer shelf lives, enhancing product stability. The wide variety of OTC drugs available in tablet and capsule forms, spanning pain relievers, vitamins, and allergy medications, catering to divorce health concerns, is presenting lucrative United States over the counter (OTC) drugs market opportunities.

Breakup by Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Others
     

Retail pharmacies exhibits a clear dominance in the market

A detailed breakup and analysis of the market based on the distribution channel have also been provided in the report. This includes hospital pharmacies, retail pharmacies, online pharmacies, and others. According to the report, retail pharmacies accounted for the largest market share.

The retail pharmacies distribution segment in the United States OTC drugs market is propelled by several factors. A prominent aspect is consumer preference for self-medication, aided by the easy availability of OTC drugs and retail pharmacies. The increased focus on preventive healthcare and Wellness, along with a growing awareness of minor ailments, drives consumers to seek accessible remedies. The convenience and accessibility of retail pharmacies cater to immediate needs, thereby favoring the growth after segment. Regulatory support for the sale of OTC drugs promotes this channel, ensuring standardized practices. Advertising and in-store promotions by pharmaceutical companies and retailers increase product visibility and influence purchasing decisions. This is further influencing the United States over the counter (OTC) drugs market revenue.

Breakup by Region:

  • Northeast
  • Midwest
  • South
  • West
     

West leads the market, accounting for the largest market share

The report has also provided a comprehensive analysis of all the major markets in the region, which include the Northeast, Midwest, South, and West. According to the report, West was the largest market for over the counter (OTC) drugs in the United States.

In the West, factors driving over the counter (OTC) drugs market include a strong emphasis on health and Wellness, leading to increased consumer awareness and demand for self-care options. The region's growing population of health-conscious individuals, along with the convenience and accessibility of OTC drugs, contribute to the market growth. The supportive regulatory environment and the presence of major pharmaceutical retailers and healthcare providers further fuel the expansion of the OTC drugs market in the West.

Competitive Landscape:

  • The report has also provided a comprehensive analysis of the competitive landscape in the market. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.
  • The competitive landscape of the United States over the counter (OTC) drugs market is characterized by a dynamic interplay of pharmaceutical companies, consumer healthcare brands, and retail chains. Established pharmaceutical giants, alongside specialized OTC-focused manufacturers, vie for market share through product innovation, brand recognition, and distribution strategies. Consumer healthcare brands leverage strong brand equity and trust built over the years to attract consumers seeking familiar and reliable options. Retailers, both traditional and online, contribute significantly by providing shelf space, accessibility, and convenience for OTC products. The landscape is marked by a diverse array of products catering to several health concerns, fostering competition within specific categories like pain relief, cold remedies, and gastrointestinal aids.


United States Over the Counter (OTC) Drugs Market News:

  • In April 2023, WellSpring Consumer Healthcare, a developer and marketer of leading over-the-counter and personal care brands, announced the acquisition of a portfolio of well-recognized and trusted over-the-counter (OTC) skincare brands from Bayer AG. Financial terms of the transaction were not disclosed. Wellspring Consumer Healthcare is a portfolio company of Avista Capital Partners, a leading middle-market healthcare private equity firm with expertise in building OTC platforms.
  • In December 2023, Novartis announced that the US Food and Drug Administration (FDA) approved Fabhalta (iptacopan) as the first oral monotherapy of the treatment of adults with paroxysmal nocturnal hemoglobinuria (PNH)1. Fabhalta is a Factor B inhibitor that acts approximally in the alternative complement pathway of the immune system, providing comprehensive control of red blood cell (RBC) destruction within on outside blood cells (intra and extravascular hemolysis).


United States Over The Counter (OTC) Drugs Market Report Scope:

Report Features Details
Base Year of the Analysis 2023
Historical Period 2018-2023
Forecast Period 2024-2032
Units US$ Billion
Scope of the Report Exploration of Historical and Forecast Trends, Industry Catalysts and Challenges, Segment-Wise Historical and Predictive Market Assessment:
  • Product Type
  • Route of Administration
  • Dosage Form
  • Distribution Channel
  • Region
Product Types Covered Cough, Cold, And Flu Products, Analgesics, Dermatology Products, Gastrointestinal Products, Vitamins, Minerals and Supplements (VMS), Weight-Loss/Dietary Products, Ophthalmic Products, Sleeping Aids, Others
Routes of Administration Covered Oral, Parenteral, Topical, Others
Dosage Forms Covered Tablets And Capsules, Liquids, Ointments, Others
Distribution Channels Covered Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others
Regions Covered Northeast, Midwest, South, West
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 3699
Five User License: US$ 4699
Corporate License: US$ 5699
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)


Key Benefits for Stakeholders:

  • IMARC’s report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the United States over the counter (OTC) drugs market from 2018-2032.
  • The research study provides the latest information on the market drivers, challenges, and opportunities in the United States over the counter (OTC) drugs market.
  • Porter's five forces analysis assist stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the United States over the counter (OTC) drugs industry and its attractiveness.
  • Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.

Key Questions Answered in This Report

We expect the United States over the counter (OTC) drugs market to exhibit a CAGR of 4.45% during 2024-2032.

The increasing adoption of OTC drugs to treat minor ailments, along with the growing demand for nutritional supplements, owing to the emerging trend of self-care, is primarily driving the United States over the counter (OTC) drugs market.

The sudden outbreak of the COVID-19 pandemic has led to the rising inclination towards OTC drugs, including antibiotics, multi-vitamin tablets, cough syrups, etc., for treating the mild symptoms of the coronavirus infection across the nation.

Based on the product type, the United States over the counter (OTC) drugs market has been divided into cough, cold and flu products, analgesics, dermatology products, gastrointestinal products, vitamins, minerals and supplements (VMS), weight-loss/dietary products, ophthalmic products, sleeping aids, and others. Among these, vitamins, minerals and supplements (VMS) currently exhibit a clear dominance in the market.

Based on the route of administration, the United States over the counter (OTC) drugs market can be categorized into oral, parenteral, topical, and others. Currently, oral holds the majority of the total market share.

Based on the dosage form, the United States over the counter (OTC) drugs market has been segregated into tablets and capsules, liquids, ointments, and others, where tablets and capsules currently account for the largest market share.

Based on the distribution channel, the United States over the counter (OTC) drugs market can be bifurcated into hospital pharmacies, retail pharmacies, online pharmacies, and others. Currently, retail pharmacies hold the majority of the total market share.

On a regional level, the market has been classified into Northeast, Midwest, South, and West, where West currently dominates the United States over the counter (OTC) drugs market.

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
United States Over The Counter (OTC) Drugs Market Report by Product Type (Cough, Cold and Flu Products, Analgesics, Dermatology Products, Gastrointestinal Products, Vitamins, Minerals and Supplements (VMS), Weight-loss/Dietary Products, Ophthalmic Products, Sleeping Aids, and Others), Route of Administration (Oral, Parenteral, Topical, and Others), Dosage Form (Tablets and Capsules, Liquids, Ointments, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others), and Region 2024-2032
Purchase options




Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us
UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More
KRISHAK BHARTI CO-OP LTD

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More
Stax

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More